Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
European Child & Adolescent Psychiatry
Published in: European Child & Adolescent Psychiatry 4/2006

01-06-2006 | ORIGINAL CONTRIBUTION

Cognitive functioning and psychiatric disorders in children with a metabolic disease

Authors: Annik Simons, MD, François Eyskens, MD, PhD, Ann De Groof, Ellen Van Diest, Dirk Deboutte, MD, PhD, Robert Vermeiren, MD, PhD

Published in: European Child & Adolescent Psychiatry | Issue 4/2006

Login to get access

Abstract

Objective

To report on the intelligence scores and the psychiatric pathology of distinct groups of children with metabolic diseases.

Methods

The study population consists of 53 children between 0 and 18 years of age. Diagnostic assessment included a semi-structured interview, self-report questionnaires and a standard intelligence test.

Results

In 40% of the children older than 5 years, a child psychiatric diagnosis was made. While CBCL total and internalizing scores did not differ between metabolic disease groups, the CBCL externalizing scores for some groups did. Two fifths of the children showed a below normal intelligence, while a performal–verbal IQ discrepancy was found in half of the children. Of the school aged children almost one third attended a special needs school.

Conclusion

In spite of the small sample size, the results suggest substantial psychiatric problems in children with a metabolic disease. Further study on larger groups is warranted, which should enable further comparison of patients affected by specific metabolic diseases.
Literature
1.
Abbott MH, Folstein SE, Abbey H, Pyeritz RE (1987) Psychiatric manifestations of homocystinuria due to cystathionine beta-synthase deficiency, prevalence, natural history, and relationship to neurological impairment and vitamin B6-responsiveness. Am J Med Genet 26:959–969PubMedCrossRef
2.
Achenbach TM (1991) Integrative guide for the 1991 CBCL 4–18, YSR, and TRF Profiles. Department of Psychiatry, University of Vermont Burlington, VT
3.
American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders IV. American Psychiatric Associationm, Washington, DC
4.
Bracken P, Coll P (1985) Homocystinuria and schizophrenia. Literature review and case report. J Nerv Mental disease 173:51–55CrossRef
5.
Brazeal T, Farmer J (1999) Natural course and treatment of neuropsychological deficits in a child with early-treated galactosemia. Child Neuropsychol 5:197–209
6.
Burgard P (2000) Development of intelligence in early treated phenylketonuria. Eur J Pediatr 159(suppl):74–79CrossRef
7.
Cleary MA, Green A (2005) Developmental delay: when to suspect and how to investigate for an inborn error of metabolism. Arch Dis Child 90:1128–1132PubMedCrossRef
8.
Eshweiler GW, Rosin R, Thier P, Giedke H (1997) Postoperative psychosis in homocystinuria. Euro Psych 12:98–101CrossRef
9.
Eyskens (1997) Screening for inborn errors of metabolism. The experience in the province of Antwerp. Doctoral Thesis. University of Antwerp
10.
Fassler D, Dumas L (1997) “Help me, I’m sad”: recognizing, treating a,d preventing childhood and adolescent depression. Viking Penguin, New York
11.
Ferguson S, Blanc A, Wardlaw J, Frier B, Perros P, McCrimmon R et al (2005) Influence of an early-onset age of Type 1 diabetes on cerebral structure and cognitive function. Diabetes Care 28:1431–1437PubMed
12.
Fombonne E (1994) The Chartres Study: I. prevalence of psychiatric disorders among French school-age children. Br J Psych 164:69–79CrossRef
13.
Gelfand K, Geffken G, Lewin A, Heidgerken A, Grove MJ, Malasanos T et al (2004) An initial evaluation of the design of pedaitric psychology consultation service with children with diabetes. J Child Health Care 8: 113–123PubMedCrossRef
14.
Ghadimi H, Binnington VI, Pecora P (1965) Hyperlysinemia associated with retardation. New Engl J Med 273:723–729PubMedCrossRef
15.
Griffiths P, Demellweek C, Fay N, Robinson P, Davidson D (2000) Wechsler subscale IQ and subtest profile in early treated phenylketonuria. Arch Dis Child 82:209–215PubMedCrossRef
16.
Harter MC (2000) Mental illness and physical disorders. Psychother Psychosom Med Psychol 50:274–286PubMedCrossRef
17.
Haworth J, Booth F, Chudley A, deGroot G, Dilling L, Goodman S, Greenberg C, Mallory C, McClarty B, Seshia S, Seargeant L (1991) Phenotypic variability in glutaric aciduria type 1: report of fourteen cases in five Canadian Indian kindreds. J Pediatr 118:52–58PubMedCrossRef
18.
Heidenreich R, Natowicz M, Hainline BE, Berman P, Kelley RI, Hillman RI, Berry GT (1988) Acute extrapyramidal syndrome in methylmalonic acidemia: “Metabolic stroke” involving the globus pallidus. J Pediatr 113:1022–1027PubMedCrossRef
19.
Hoffmann GF, von Kries R, Klose D, Lindner M, Shulze A, Muntau AC, Röschinger W, Liebl B, Mayatepek E, Roscher AA (2004) Frequencies of inherited organic acidurias and disorders of mitochondrial fatty acid transport and oxidation in Germany. Eur J Ped 163:76–80CrossRef
20.
Huijbrechts SC, de Sonneville LM, Licht R, van Spronsen FS, Verkerk PH, Sergeant JA (2002) Sustained attention and inhibition of cognitive interference in treated phenylketonuria: associations with concurrent and lifetime phenylalanine concentrations. Neuropsychologia 40:7–15CrossRef
21.
Huisman J, Van Der Schot L, Hendrikx M, Kalverboer A, Slijper (1992) De intellectuele ontwikkeling van patiënten met fenylketonurie: 15 jaar landelijke screening in Nederland. Ned Tijdschr Geneeskd 136:2277–2280PubMed
22.
Kanner S, Hamrin V, Grey M (2003) Depression in adlescents with diabetes. J Child Adolsc Psychiatr Nurs 16:15–24
23.
Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, Williamson D, Ryan N (1997) Schedule for Affective Disorders ans Schizophrenia for School-Age Children-Present and Lifetime version (K-SADS-PL): initial reliability and validity data. J AM Acad Child Adolesc Psychiatr 36:980–988CrossRef
24.
Manis FR, Cohn LB, McBride-Chang C, Wolff JA, Kaufman FR (1997) A longitudinal study of cognitive functioning in patients with classical galactosemia, including a cohort treated with oral uridine. J Inherit Metabolc diseases 20:549–555CrossRef
25.
Masi G (1998) Psychiatric illness in mentally retarted adolescents: clinical features. Adolescence 33:425–434PubMed
26.
Matteson A (1972) Long-term physical illness in childhood: a challenge to psychosocial adaptation. Pediatrics 50:801–811
27.
McCarthy A, Lindgren S, Mengeling M, Tsalikian E, Engvall J (2002) Effects of diabetes on learning in children. Pediatrics 109:E9PubMedCrossRef
28.
Nakai A, Shigematsu Y, Saito M, Kikawa Y, Sudo M (1991) Pathophysiology study on methylmalonic aciduria: decrease in liver high-energy phosphate after propionate loading in rats. Pediatr Res 30:5–12PubMed
29.
Nelson CD, Waggoner DD, Donell GN, Tuerck JM, Buist NRM (1991) Verbal dyspraxia in treated galactosemia. Pediatrics 88:346–350PubMed
30.
Nicolaides P, Leonard J, Surtees R (1998) Neurological outcome of methylmalonic acidaemia. Arch Dis Child 78:508–512PubMed
31.
Nissenkorn A, Zeharia A, Lev D, Watemberg N, Fattel-Valevski A, Barash V, Gutman A, Harel S, Lerman-Sagie T (2000) Neurologic presentations of mitochondrial disorders. J Child Neurol 15:44–48PubMed
32.
Northam E, Andersonn P, Jacobs R, Hughes M, Warne G, Werther G (2001) Neuropsychological profiles of children with type 1 diabetes 6 years after disease onset. Diabetes Care 24:1541–1546PubMed
33.
Oliveira G, Diogo L, Grazina P, Ataide A, Marques C, Miquel T (2005) Mitochondrial dysfunction in autism spectrum disorders: a population-based study. Dev Med Child Neurol 47:185–189PubMedCrossRef
34.
Pietz J, Fätkenheuer B, Burgard P, Armbruster M, Esser G, Schmidt H (1997) Psychiatric disorders in adult patients with early-treated phenylketonuria. Pediatrics 99:345–350PubMedCrossRef
35.
Sartor H, Loose R, Tucha O, Klein HE, Loye KW (2002) MELAS: a neuropsychological and radiological follow-up study. Acta Neurol Scand 106:303–313CrossRef
36.
Scriver B, Valle, S (2001) The metabolic, molecular bases of inherited disease, 8th edn., In: Scriver B, Valle S (eds) Mc Grow-Hill, pp 1327–1403
37.
Smith I, Knowles J (2000) Behaviour in early treated phenylketonuria: a systematic review. Eur J Pediatr 159(suppl):89–93CrossRef
38.
Snijders JT, Tellegen PJ, Laros JA (1988) Snijders-Oomen Niet verbale Intelligentietest SON-R 51/2—17. Verantwoording en handleiding. Groningen, Wolters–Noordhoff
39.
Sullivan J, Chang P (1999) Review: Emotional and behavioral functioning in phenylketonuria. J Pediatr Psychol 24:281–299PubMedCrossRef
40.
Suzuki T, Koizumi J, Shiraishi H, Ofuku K, Sasaki M, Hori T, Oskoshi N (1989) Psychiatric disturbance in mitochondrial encephalomyopathy. J Neurol Neurosurg Psych 52(7):920–922
41.
Thomeer E, Verhoeven W, van de Vlasakker C, Klompenhouwer J (1998) Psychiatric symptoms in MELAS: a case report. J Neurol Neurosurg Psychiatr 64:692–693PubMedCrossRef
42.
Tierney E, Nwokoro NA, Kelley RI (2000) Behavioral phenotype of RHS/ Smith–Lemli–Opitz syndrome. Mental Retard Develop Disabil Res Rev 6:131–134CrossRef
43.
Trifiletti R, Packard A (1999) Metabolic disorders presenting with behavioral symptoms in the school-aged child. Child Adoles Psychiatr Clin N Am 8:791–806
44.
Turconi AC, Benti R, Castelli E, Pochinesta S, Felisari G, Comi G, Gagliardi C, Del Piccolo L, Bresolin N (1999) Focal and cognitive impairment in mitochondrial encephalomyopathies: a neuropsychological and neuroimaging study. J Neurol Sci 170:57–63PubMedCrossRef
45.
van der Meulen BF, Smrkovsky M (1987) BOS 2–30. Handleiding bij de niet-verbale versie. Swets & Zeitlinger, Lisse
46.
Verhulst FC, van der Ende J, Koot HM (1996) Handleiding voor de CBCL/4–18. Afdeling Kinder- en Jeugdpsychiatrie, Sophia Kinderziekenhuis, Erasmus Universiteit Rotterdam, Rotterdam
47.
Verhulst FC, van der Ende J, Koot HM (1997) Handleiding voor de Youth Self –Report (YSR). Afdeling Kinder-en Jeugdpsychiatrie, Sophia Kinderziekenhuis, Erasmus Universiteit, Rotterdam
48.
Waisbren S, Brown M, de Sonneville L, Levy H (1994) Review of neuropsychological functioning in treated phenylketonuria: an information processing approach. Acta Paediatr 407(suppl):98–103
49.
Wechsler D (1952) Wechsler intelligence scale for children. Psychological Corporation, New York
50.
Wechsler D (1989) Maual for the Wechsler Preschool and primary scale of intelligence—revised (WPPSI-R). The Psychological Corporation, New York
51.
Weglage J, Funders B, Ullrich K, Rupp A, Schmidt E (1996) Psychosocial aspects in phenylketonuria. Eur J Pediatr 155:S101–S104PubMedCrossRef
52.
Yap S, Rushe H, Howard PM, Naugthen ER (2001) The intellectual abilities of early-treated individuals with pyridoxine-nonresponsive homocystinuria due to cysthionine beta-synthase deficiency. J Inherit Metab Dis 24:437–447PubMedCrossRef
Metadata
Title
Cognitive functioning and psychiatric disorders in children with a metabolic disease
Authors
Annik Simons, MD
François Eyskens, MD, PhD
Ann De Groof
Ellen Van Diest
Dirk Deboutte, MD, PhD
Robert Vermeiren, MD, PhD
Publication date
01-06-2006
Publisher
Steinkopff-Verlag
Published in
European Child & Adolescent Psychiatry / Issue 4/2006
Print ISSN: 1018-8827
Electronic ISSN: 1435-165X
DOI
https://doi.org/10.1007/s00787-006-0524-9

Other articles of this Issue 4/2006

European Child & Adolescent Psychiatry 4/2006 Go to the issue

BOOK REVIEW

Tics and Tourette Syndrome – A Handbook for Parents and Professionals

ORIGINAL CONTRIBUTION

Do antidepressants precipitate youth suicide?

ORIGINAL CONTRIBUTION

Suicidal ideation, deliberate self-harm behaviour and suicide attempts among adolescent outpatients with depressive mood disorders and comorbid axis I disorders

ORIGINAL CONTRIBUTION

Current comorbidity among consecutive adolescent psychiatric outpatients with DSM-IV mood disorders

ORIGINAL CONTRIBUTION

Behavioural problems and autism in children with hydrocephalus

ORIGINAL CONTRIBUTION

Does pervasive developmental disorder protect children and adolescents against drug and alcohol use?